Drug intelligence / Profile preview

Celevis

Development stage
Unknown
Lead developer
Giuliani
Administration
Rectal, Topical
01

Overview

Celevis is a topical medical device developed by the Italian pharmaceutical company Giuliani, specifically formulated as a gel for the management of proctological conditions such as anal fissures and hemorrhoids. The product functions primarily by creating a protective mechanical barrier over the anal mucosa, which shields the affected tissue from external irritants and reduces symptoms like pain, itching, and burning. Its key component is typically hyaluronic acid (sodium hyaluronate), which provides essential hydration and supports the natural healing and repair processes of the mucosal lining. Celevis is marketed as a non-pharmacological treatment option for patients seeking relief from the discomfort associated with anorectal disorders and is part of Giuliani's gastrointestinal and proctological portfolio.

Brand names
Celevis
Other names
Celevis Gel
02

Targets

CD44 (CD44 antigen)

Beyond the preview

Go deeper on Celevis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Celevis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call